These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 16166327

  • 1. Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice.
    Wei WZ, Jacob JB, Zielinski JF, Flynn JC, Shim KD, Alsharabi G, Giraldo AA, Kong YC.
    Cancer Res; 2005 Sep 15; 65(18):8471-8. PubMed ID: 16166327
    [Abstract] [Full Text] [Related]

  • 2. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody.
    Morris GP, Kong YC.
    J Autoimmun; 2006 Feb 15; 26(1):24-31. PubMed ID: 16253477
    [Abstract] [Full Text] [Related]

  • 3. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
    Reilly RT, Machiels JP, Emens LA, Ercolini AM, Okoye FI, Lei RY, Weintraub D, Jaffee EM.
    Cancer Res; 2001 Feb 01; 61(3):880-3. PubMed ID: 11221874
    [Abstract] [Full Text] [Related]

  • 4. Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice.
    Sakai Y, Morrison BJ, Burke JD, Park JM, Terabe M, Janik JE, Forni G, Berzofsky JA, Morris JC.
    Cancer Res; 2004 Nov 01; 64(21):8022-8. PubMed ID: 15520211
    [Abstract] [Full Text] [Related]

  • 5. CD4+CD25+ naturally occurring regulatory T cells and not lymphopenia play a role in the pathogenesis of iodide-induced autoimmune thyroiditis in NOD-H2h4 mice.
    Nagayama Y, Horie I, Saitoh O, Nakahara M, Abiru N.
    J Autoimmun; 2007 Nov 01; 29(2-3):195-202. PubMed ID: 17826032
    [Abstract] [Full Text] [Related]

  • 6. Anti-HER-2/neu immune responses are induced before the development of clinical tumors but declined following tumorigenesis in HER-2/neu transgenic mice.
    Takeuchi N, Hiraoka S, Zhou XY, Nagafuku M, Ono S, Tsujimura T, Nakazawa M, Yura Y, Hamaoka T, Fujiwara H.
    Cancer Res; 2004 Oct 15; 64(20):7588-95. PubMed ID: 15492286
    [Abstract] [Full Text] [Related]

  • 7. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H, Wang S, Zhang D, Hou S, Qian W, Li B, Guo H, Kou G, He J, Wang H, Guo Y.
    Clin Cancer Res; 2009 Jul 15; 15(14):4612-21. PubMed ID: 19584156
    [Abstract] [Full Text] [Related]

  • 8. Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance.
    Chung Y, Lee SH, Kim DH, Kang CY.
    J Leukoc Biol; 2005 Jun 15; 77(6):906-13. PubMed ID: 15758078
    [Abstract] [Full Text] [Related]

  • 9. Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors.
    Gao Y, Whitaker-Dowling P, Griffin JA, Barmada MA, Bergman I.
    Cancer Gene Ther; 2009 Jan 15; 16(1):44-52. PubMed ID: 18654610
    [Abstract] [Full Text] [Related]

  • 10. Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice.
    Jacob J, Radkevich O, Forni G, Zielinski J, Shim D, Jones RF, Wei WZ.
    Cell Immunol; 2006 Apr 15; 240(2):96-106. PubMed ID: 16930573
    [Abstract] [Full Text] [Related]

  • 11. Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function.
    de León J, Fernández A, Clavell M, Labrada M, Bebelagua Y, Mesa C, Fernández LE.
    Int Immunol; 2008 Apr 15; 20(4):591-600. PubMed ID: 18310617
    [Abstract] [Full Text] [Related]

  • 12. Control of Her-2 tumor immunity and thyroid autoimmunity by MHC and regulatory T cells.
    Jacob JB, Kong YC, Meroueh C, Snower DP, David CS, Ho YS, Wei WZ.
    Cancer Res; 2007 Jul 15; 67(14):7020-7. PubMed ID: 17638915
    [Abstract] [Full Text] [Related]

  • 13. Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens.
    Golgher D, Jones E, Powrie F, Elliott T, Gallimore A.
    Eur J Immunol; 2002 Nov 15; 32(11):3267-75. PubMed ID: 12555672
    [Abstract] [Full Text] [Related]

  • 14. Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity.
    Jacob JB, Kong YC, Nalbantoglu I, Snower DP, Wei WZ.
    J Immunol; 2009 May 01; 182(9):5873-81. PubMed ID: 19380836
    [Abstract] [Full Text] [Related]

  • 15. IL-12 prevents tolerance induction with mouse thyroglobulin by priming pathogenic T cells in experimental autoimmune thyroiditis: role of IFN-gamma and the costimulatory molecules CD40l and CD28.
    Zhang W, Flynn JC, Kong YC.
    Cell Immunol; 2001 Feb 25; 208(1):52-61. PubMed ID: 11277619
    [Abstract] [Full Text] [Related]

  • 16. Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent.
    Valzasina B, Piconese S, Guiducci C, Colombo MP.
    Cancer Res; 2006 Apr 15; 66(8):4488-95. PubMed ID: 16618776
    [Abstract] [Full Text] [Related]

  • 17. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
    Keino H, Takeuchi M, Kezuka T, Hattori T, Usui M, Taguchi O, Streilein JW, Stein-Streilein J.
    Invest Ophthalmol Vis Sci; 2006 Mar 15; 47(3):1047-55. PubMed ID: 16505040
    [Abstract] [Full Text] [Related]

  • 18. CD25+ regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritis.
    Morgan ME, Witteveen HJ, Sutmuller RP, de Vries RR, Toes RE.
    Hum Immunol; 2004 Nov 15; 65(11):1319-27. PubMed ID: 15556682
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
    Fukuhara H, Matsumoto A, Kitamura T, Takeuchi T.
    BJU Int; 2006 Jun 15; 97(6):1314-21. PubMed ID: 16686731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.